Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ATP plays a structural role in Hsp90 function.

Nature communications·2025
Same author

Development and optimization of human T-cell leukemia virus-specific antibody-dependent cell-mediated cytotoxicity (ADCC) assay directed to the envelope protein.

Journal of virology·2025
Same author

The Properties and Domain Requirements for Phase Separation of the Sup35 Prion Protein In Vivo.

Biomolecules·2023
Same author

Overexpression of Hsp104 by Causing Dissolution of the Prion Seeds Cures the Yeast [<i>PSI</i>] Prion.

International journal of molecular sciences·2023
Same author

Nucleotide exchange is sufficient for Hsp90 functions in vivo.

Nature communications·2023
Same author

Hsp70 Binding to the N-terminal Domain of Hsp104 Regulates [<i>PSI</i>] Curing by Hsp104 Overexpression.

Molecular and cellular biology·2023

Related Experiment Video

Updated: Jun 6, 2026

Identifying Protein-protein Interaction Sites Using Peptide Arrays
07:44

Identifying Protein-protein Interaction Sites Using Peptide Arrays

Published on: November 18, 2014

Mapping mouse IL-13 binding regions using structure modeling, molecular docking, and high-density peptide microarray

Satish K Madala1, Michael A Dolan, Deepak Sharma

  • 1Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA.

Proteins
|November 11, 2010
PubMed
Summary

Researchers mapped how Interleukin-13 (IL-13) binds to its receptors, revealing new binding sites and enabling the creation of a targeted antibody for allergic asthma and helminth infections.

More Related Videos

Quantification of Protein Interaction Network Dynamics using Multiplexed Co-Immunoprecipitation
07:57

Quantification of Protein Interaction Network Dynamics using Multiplexed Co-Immunoprecipitation

Published on: August 21, 2019

Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis
09:32

Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis

Published on: October 15, 2021

Related Experiment Videos

Last Updated: Jun 6, 2026

Identifying Protein-protein Interaction Sites Using Peptide Arrays
07:44

Identifying Protein-protein Interaction Sites Using Peptide Arrays

Published on: November 18, 2014

Quantification of Protein Interaction Network Dynamics using Multiplexed Co-Immunoprecipitation
07:57

Quantification of Protein Interaction Network Dynamics using Multiplexed Co-Immunoprecipitation

Published on: August 21, 2019

Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis
09:32

Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis

Published on: October 15, 2021

Area of Science:

  • Immunology
  • Molecular Biology
  • Structural Biology

Background:

  • Interleukin-13 (IL-13) is a key cytokine in allergic asthma and helminth infections, mediating mucus production, inflammation, and tissue remodeling.
  • IL-13 signals through the type-II IL-4 receptor (composed of IL-13Rα1 and IL-4Rα) and also binds IL-13Rα2 with higher affinity, which can attenuate signaling.
  • The molecular basis for mouse IL-13's specific binding to these receptors remains largely uncharacterized.

Purpose of the Study:

  • To elucidate the molecular determinants governing the binding specificity and affinity of mouse IL-13 to its receptors, IL-13Rα1 and IL-13Rα2.
  • To identify unique binding sequences for each receptor to facilitate the development of targeted therapeutics.

Main Methods:

  • Utilized high-density overlapping peptide arrays to map IL-13 binding sites.
  • Employed structural modeling and molecular docking to analyze binding interactions.
  • Performed site-directed mutational analysis and compared findings with human receptor structures.

Main Results:

  • Mapped IL-13 binding sequences on mouse IL-13Rα1 and IL-13Rα2, consistent with existing human structural data.
  • Identified novel structural differences at the IL-13 binding interface between the receptors.
  • Discovered additional binding sites for IL-13 on IL-13Rα2 and unique peptide sequences for IL-13Rα1.

Conclusions:

  • High-density peptide arrays and molecular docking offer a rapid and reliable method for mapping cytokine-receptor interactions.
  • The identified unique binding sequences enabled the generation of a monoclonal antibody specific to IL-13Rα1.
  • This approach can be leveraged to develop antagonists targeting specific IL-13 receptor interactions for therapeutic purposes.